Diabetes being a chronic multisystem disease with end-organ damage, it would be natural to expect raised serum EPO, especially with coexisting nephropathy and anaemia.
The authors have shown ingenuity in their study; however, we reckon that it would have been better served with a comprehensive outlook of the risk factors being studied. We appreciate the comments of Dr Uparkar regarding our article. We agree that serum erythropoietin (EPO) is expected to be raised in diabetic patients. However, we showed that vitreous EPO levels were raised because of intraocular production in our earlier article. 1 Dr Uparkar states that it would be fallacious to compare the acute imbalance or retinal vein occlusions with diabetic macular oedema (DME), a chronic condition. However, other vitreous factors, such as vascular endothelial growth factor (VEGF), are raised in both diseases; 2, 3 hence, we believe our study is not so fallacious. We agree that systemic factors are related with EPO production, but we remind Dr Uparkar that, as mentioned above, intraocular production was responsible for raised vitreous EPO levels. We read with interest the article entitled 'Tonometer disinfection practice in the United Kingdom: a national survey,' 1 and agree with the conclusion that guidelines for tonometer disinfection in the United Kingdom are necessary. We would like to comment on the article's surprising finding that 23% of ophthalmology units with training recognition have adopted exclusive use of disposable tonometer prisms despite evidence that there is still a risk of transmission of pathogens when using these, 2 and that they are less accurate than a Goldmann prism. 3 In the absence of concrete evidence of reduced risk of transfer of viral and bacterial pathogens and controversy about the small theoretical risk of transmission of vCJD, 4 we must consider the financial and environmental costs associated with the use of disposable prisms. If we assume that an average ophthalmologist sees 4000 patients per annum, the cost of two non-disposable Goldmann prisms and 36 l of 0.5% sodium hypochlorite solution would be d244 per annum. The cost for Tonosafe disposable prisms for this number of patients would be d2324 (personal communication, Haag Streit). This amounts to a cost per patient of 58.1 pence for the Tonosafe prism and 6.1 pence for the non-disposable prism, a difference in cost per doctor per annum of d2080. Waste produced per 4000 patients using non-disposable prisms is 48 plastic bottles, whereas using disposable prisms results in 5.52 kg of plastic and 1.68 kg of paper waste. There are approximately 2500 consultants, associate specialists, and trainee ophthalmologists working in the United Kingdom (Royal College of Ophthalmologists, personal communication). If all of these were to use disposable Tonosafe prisms, this would result in an approximate added cost to the NHS of d5.2 million per annum and the production of 4.2 tonnes more paper waste, and 13.8 tonnes more plastic waste than if non-disposable prisms were used. Climate change is happening and mankind is believed to be responsible. 5 In the absence of a strong case for disposable prism use, guidelines on disinfection can support practice which reduces the risk of cross contamination to acceptable levels, reduces costs and reduces the contribution of ophthalmologists to climate change.
Sir, Reply to Dr Somner
We thank Somner and Lockington for their comments. They bring an interesting perspective to the debate of disposable vs non-disposable tonometer heads. The financial and environmental impact of the disposable tonometer they describe has not been described in this detail before and may influence the practice of units in the United Kingdom.
The national survey on tonometer disinfection highlights that units in the United Kingdom may be using disinfection practices that are insufficient based on currently published guidelines. The facts that some units do not have two tonometers per doctor, that soaking times may be inadequate for sufficient disinfection, that rinsing practices of tonometers may not be sufficient, and that the strength and type of disinfection solutions in use may not be appropriate all lead us to believe that this may leave patients at risk of cross contamination and an iatrogenic infection. 1 Outbreaks of epidemic keratoconjunctivitis from well reputed eye units have been documented, and tonometers have been implicated as one of the potential sources for the spread of these epidemics. 2, 3 The department of health has instituted an advisory committee for dangerous pathogens (ACDP), for transmission of spongiform encephalopathy, with an ophthalmic subgroup, which is in the process of drafting guidelines for disinfection practices for instruments used in the specialty. Their guidelines are due to be published towards the end of 2008 and include a disinfection guideline for non-disposable instruments (including tonometer heads), which will be more stringent and potentially more difficult to adhere to than currently published guidelines. Their guidelines will recommend that if strict disinfection practices cannot be adhered to, the use of disposable instruments should be considered when these are available (personal communication from the ACDP, Ophthalmology subgroup).
We believe that units that cannot adhere to a safe and acceptable tonometer disinfection practice, which adheres to published guidelines, should consider the use of a disposable tonometer head as the financial, legal, and public relations impact of an outbreak of epidemic keratoconjunctivitis or the iatrogenic spread of infection because of inadequate disinfection practices would be considerable.
